NasdaqGS - Nasdaq Real Time Price USD
Vigil Neuroscience, Inc. (VIGL)
2.3200
-0.0500
(-2.11%)
At close: May 15 at 4:00:00 PM EDT
2.2900
-0.03
(-1.29%)
Pre-Market: 5:09:13 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.47 | -0.48 | -1.94 | -1.54 |
| Low Estimate | -0.5 | -0.53 | -2.07 | -2.03 |
| High Estimate | -0.43 | -0.44 | -1.81 | -0.64 |
| Year Ago EPS | -0.52 | -0.47 | -2.07 | -1.94 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | -- | -- | -- | 10.04M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 70.25M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.52 | -0.54 | -0.47 | -0.55 |
| EPS Actual | -0.52 | -0.47 | -0.57 | -0.49 |
| Difference | 0 | 0.07 | -0.1 | 0.06 |
| Surprise % | 0.00% | 12.15% | -21.28% | 10.09% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.47 | -0.48 | -1.94 | -1.54 |
| 7 Days Ago | -0.55 | -0.56 | -2.21 | -1.5 |
| 30 Days Ago | -0.55 | -0.56 | -2.21 | -1.5 |
| 60 Days Ago | -0.54 | -0.59 | -2.06 | -1.56 |
| 90 Days Ago | -0.54 | -0.59 | -2.06 | -1.56 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VIGL | 9.62% | -2.84% | 6.44% | 20.31% |
| S&P 500 | 13.17% | 2.85% | 7.92% | 13.78% |
Upgrades & Downgrades
| Reiterates | Wedbush: Outperform to Outperform | 5/5/2025 |
| Maintains | Wedbush: Outperform to Outperform | 3/14/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/14/2025 |
| Reiterates | Guggenheim: Buy to Buy | 1/24/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/23/2025 |
| Initiated | William Blair: Outperform | 12/4/2024 |
Related Tickers
ACRV Acrivon Therapeutics, Inc.
1.1000
-3.51%
RAPP Rapport Therapeutics, Inc.
9.76
+1.30%
MBX MBX Biosciences, Inc.
10.65
+4.72%
RLYB Rallybio Corporation
0.3201
+3.42%
ARTV Artiva Biotherapeutics, Inc.
2.1300
+17.68%
KYMR Kymera Therapeutics, Inc.
30.02
+0.91%
OKUR OnKure Therapeutics, Inc.
2.0600
+12.57%
ABOS Acumen Pharmaceuticals, Inc.
1.0100
+3.06%
AGIO Agios Pharmaceuticals, Inc.
28.26
+0.82%
ALXO ALX Oncology Holdings Inc.
0.4358
-5.14%